MIKE25y
評論了
$Virax Biolabs (VRAX.US)$
Shares of nano-cap diagnostics company Virax Biolabs Group (NASDAQ:VRAX) more than doubled in value in the morning hours Thursday as the company drew Wall Street's attention amid a rising number of bird flu cases worldwide.
Several countries, including the U.S., have already reported human bird flu infections as the highly pathogenic avian influenza virus, including its H5N1 form, continues to spread in poultry and cattle.
Shares of nano-cap diagnostics company Virax Biolabs Group (NASDAQ:VRAX) more than doubled in value in the morning hours Thursday as the company drew Wall Street's attention amid a rising number of bird flu cases worldwide.
Several countries, including the U.S., have already reported human bird flu infections as the highly pathogenic avian influenza virus, including its H5N1 form, continues to spread in poultry and cattle.
3
MIKE25y
評論了
$Regulus Therapeutics (RGLS.US)$regulus therapeutics宣布私募股權定向增發,總額10000萬美元,每股價格1.60美元,超額認購。
SAN DIEGO,2024年3月12日/PRNewswire/ -- regulus therapeutics inc.(納斯達克: RGLS),一家專注於發現和研發革命性microRNA相應藥物的生物製藥公司,宣布已達成一項定向增發證券購買協議,向某些機構進行私募。 RGLS,一家專注於發現和研發革命性microRNA相應藥物的生物製藥公司,今天宣布已達成一項定向增發證券購買協議,向某些機構進行私募。
SAN DIEGO,2024年3月12日/PRNewswire/ -- regulus therapeutics inc.(納斯達克: RGLS),一家專注於發現和研發革命性microRNA相應藥物的生物製藥公司,宣布已達成一項定向增發證券購買協議,向某些機構進行私募。 RGLS,一家專注於發現和研發革命性microRNA相應藥物的生物製藥公司,今天宣布已達成一項定向增發證券購買協議,向某些機構進行私募。
已翻譯
1
MIKE25y : 有啥關係呢 ………
MIKE25y QuintusChen : 這個公司都沒有這方面的收入,你的利好對他們來說就是虛假